← All trials
NCT03208972
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2014
- Primary completion
- Nov 30, 2015
- Completion date
- Nov 30, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 107
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- AZ Jan Palfijn GentLead sponsor
- AZ Jan Palfijn GentReponsible party - principal investigator
- AZ Jan Palfijn GentOverall official - principal investigator
- Onze Lieve Vrouw HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.